Search results
Found 1365 matches for
An internationally recognised centre of excellence for biomedical and clinical research and teaching
COVID: media must rise above pitting scientists against each other – dealing with the pandemic requires nuance
Coronavirus COVID-19 General
26 July 2021
COVID: the reason cases are rising among the double vaccinated – it’s not because vaccines aren’t working
Coronavirus COVID-19 General Research
22 July 2021
Urgent need for COVID-19 vaccine equity: UN-Oxford research
Coronavirus COVID-19 General
22 July 2021
COVID-19 vaccine programmes are expected to cost poorer countries an additional 56.6% on health budgets, compared with just 0.8% on wealthy countries’ health expenditure, according to new data from the United Nations Development Programme (UNDP), the World Health Organisation (WHO) and the University of Oxford.
Difficulty hearing speech could be a risk factor for dementia
General Research
22 July 2021
A new study led by University of Oxford researchers on over 82,000 participants has shown that difficulty hearing spoken conversations is associated with up to 91% increased risk of dementia.
Red and processed meat linked to increased risk of heart disease, Oxford study shows
General Research
22 July 2021
Largest review of all large-scale studies to date finds red and processed meat increase the risk of heart disease.
How did people in Europe and SE Asia experience the first COVID-19 wave?
Coronavirus COVID-19 General Research
21 July 2021
An international team, led by Phaik Yeong Cheah, conducted an anonymous online survey from May-June 2020, asking 5,058 people in Thailand, Malaysia, United Kingdom, Italy and Slovenia to share their experiences. Anne Osterrieder and colleagues in the Centre for Tropical Medicine & Global Health (Nuffield Department of Medicine) report the unequal impacts of public health measures, and the prevalence of ‘fake news’.
New research studies to help diagnose and treat Long COVID funded by NIHR
Coronavirus COVID-19 General Research
19 July 2021
Three projects at Oxford have received funding from NIHR to assess breathlessness in Long COVID patients, investigate the impact of Long COVID on families, and examine the role of vaccines in Long COVID.
ISARIC COVID-19 clinical database passes ½ million patient records mark
Coronavirus COVID-19 General Research
19 July 2021
COVID-19 has exposed our vulnerability to pandemic infections and shown what works, and what does not. It has tested the effectiveness of the Oxford-based global, open-source, collaborative approach set up 10 years ago to prevent illness and deaths from infectious disease outbreaks: ISARIC, the International Severe Acute Respiratory and Emerging Infection Consortium.
T-cell ‘training grounds’ behind robust immune system response seen in adenovirus vaccines
Coronavirus COVID-19 General Research
19 July 2021
Adenovirus vaccine vectors, such as the ChAdOx1 nCov-19 construct which has risen to prominence as a major vaccine for COVID-19, may generate robust long-term immune system responses, according to scientists from the Universities of Oxford and the Cantonal Hospital St.Gallen, Switzerland.
Lateral flow tests are 95% effective at detecting Covid-19 when used at the onset of symptoms
Coronavirus COVID-19 General Research
15 July 2021
A new study by researchers at the University of Oxford, Queen Mary University of London, Institute for Advanced Studies, Vienna, and the Medical University of Graz, has found that lateral flow tests detect Covid-19 with similar accuracy to laboratory-based PCR tests, providing they are used at the onset of infection and soon after symptoms start.
Developing new ways to assess kidneys so transplants last for longer
General Research
15 July 2021
With funding from Kidney Research UK, a team of researchers from the University of Oxford, the University of Nottingham and University College London will develop ways to assess donor kidneys and predict how well they will work after transplant.
Not a tea lady: The prime of Professor Dame Kay Davies
General
14 July 2021
After almost 50 years at Oxford, Professor Dame Kay Davies is soon to retire – well…. mostly… Kay talks to Sarah Whitebloom about her early years at Somerville fresh out of state school, how she balanced motherhood with the demands of her burgeoning career, and her long held passion to find a cure for Duchenne muscular dystrophy. Thank you Kay for your long years of service and dedication. You are truly an inspiration to many!
High blood sugar levels ‘reprogramme’ stem cells
General Research
14 July 2021
Findings explain higher risk of heart attack in people with diabetes, even after treatment.
COVID: seven reasons mask wearing in the west was unnecessarily delayed
Coronavirus COVID-19 General Research
14 July 2021
New network Oxford Cancer launches
General
14 July 2021
A new pan-divisional initiative has launched at the University of Oxford, bringing together the collective force of cancer research, outreach and care that happen across the city of Oxford.
Oxford overseas research facility expands to include diagnostics and genetics testing centre
General Innovation
12 July 2021
The Oxford-Suzhou Centre for Advanced Research, known as OSCAR, has marked another significant milestone with the launch of OSCAR-Prenetics Innovation and Technology Centre for Advanced Molecular Diagnostics (the OSCAR-Prenetics ITC).
Oxford holds in-person graduation ceremony for medical-students joining the NHS frontline
General
12 July 2021
Oxford holds in-person graduation ceremony for medical-students joining the NHS frontline
Feeling Safe works: effective treatment for paranoia follows a decade of Oxford research
General Research
9 July 2021
Professor Daniel Freeman, clinical psychologist, explains how delusions may be unfounded but they cause real distress and misery for sufferers - who feel constantly unsafe. He set himself the challenge of finding an effective treatment, a decade later he and colleagues have unveiled Feeling Safe, which shows real benefits for trial participants and, he hopes, a step change in the treatment of severe paranoia.
First major study of new HIV therapy opens to recruitment
General Research
7 July 2021
The RIO clinical trial will test whether a new type of therapy can keep HIV under control without daily antiretroviral treatment (ART) tablets.